My Time as Deputy Director for Intramural Research: What the Future Holds
I’m excited that the next Deputy Director for Intramural Research (DDIR) will bring new energy to NIH’s intramural research program (IRP). In preparation for the transition to new leadership—including a new NIH Director—I have worked closely with NIH scientific and clinical directors to identify four areas of challenges and opportunities that will need to be addressed.
Read about NIH scientific advances and discoveries by intramural scientists: complete human genome sequenced; hydration may reduce long-term cardiac risk; peripheral vision attention not driven by tiny eye movements; targeting fat-cell signaling may help treat metabolic disease; newly discovered molecular pathway in two neurodegenerative disorders; and machine learning successfully identifies ALS subtypes.
Since the beginning of the AIDS epidemic in the 1980s, scientists at the National Cancer Institute (NCI) have made several pivotal discoveries in HIV and AIDS and AIDS-associated cancers. Four decades later, NCI senior investigator Genoveffa Franchini is close to finding a vaccine approach to prevent HIV infection and AIDS.
Many fellows at the NIH share an interest in developing innovative new drug targets, diagnostics, therapies, and technologies and finding ways to move them from the bench to the bedside. But what does it take to bring innovations into the public realm? The answer often lies in technology transfer.
Two soon-to-be demolished buildings—the Biologics Standards Laboratory Building (Building 29) and the Biologics Standards Laboratory Annex (Building 29A)—are nationally significant to the history of medicine and public health. They will live on in a new website hosted by the Office of NIH History and Stetten Museum.
News From and About the Scientific Interest Groups
Two new SIGS: The Consciousness Research Interest Group will provide a platform to discuss, discover, collaborate, and stimulate the research of the science of consciousness; the Metastasis Scientific Interest Group will support metastasis-related research at the NIH.